Northwest & Ethical Investments L.P.
Position in RDY — Dr Reddys Laboratories Ltd
CIK 2033536
TORONTO, A6
Position in RDY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$854,434
New position
Shares Held
61,692
first reported quarter
Ownership
0.007%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Northwest & Ethical Investments L.P. holds $35,891,165 across 6 Drug Manufacturers - Specialty & Generic names. RDY ranks #4 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
251,525 | $29,732,770 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
5,650 | $3,350,337 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
32,470 | $977,996 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
This page
|
61,692 | $854,434 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
31,019 | $742,284 | |
| 6 | BHC |
Bausch Health Companies Inc.
|
43,212 | $233,344 |
All Filings in RDY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $854,434 | 61,692 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||